These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 20037202)

  • 21. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs.
    Tomek S; Horak P; Pribill I; Haller G; Rössler M; Zielinski CC; Pils D; Krainer M
    Gynecol Oncol; 2004 Jul; 94(1):107-14. PubMed ID: 15262127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of in vitro human keratinocyte models to study the effect of cooling on chemotherapy drug-induced cytotoxicity.
    Al-Tameemi W; Dunnill C; Hussain O; Komen MM; van den Hurk CJ; Collett A; Georgopoulos NT
    Toxicol In Vitro; 2014 Dec; 28(8):1366-76. PubMed ID: 25091624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testing fish vaccines with an in vitro lymphocyte blastogenesis assay.
    Pund RP; Nold K; Henrion E
    ALTEX; 1998; 15(5):75-79. PubMed ID: 11178549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathological studies on the influence of a photosensitizing dye, platonin, upon anti-cancer drugs].
    SUZUE K; TANAKA M
    Gan; 1956 Dec; 47(3-4):415-6. PubMed ID: 13415062
    [No Abstract]   [Full Text] [Related]  

  • 28. [Studies on rapid in vitro screening tests for anti-tumor substances; cap, ink and paper-methods].
    YAMAMOTO T; NISHIOKA K; ODA A; YOSHIDA T; KINUKAWA H; GOMIBUCHI A
    Gan; 1957 Dec; 48(4):397-9. PubMed ID: 13524421
    [No Abstract]   [Full Text] [Related]  

  • 29. Anti-cancer effect of azopyrimidines.
    TANAKA K; KAZIWARA K; ARAMAKI Y; OMURA E; ARAKI T; WATANABE J; KAWASHIMA M; SUGAWA T; SANNO Y; SUGINO Y; ANDO Y; IMAI K
    Gan; 1956 Dec; 47(3-4):401-4. PubMed ID: 13415056
    [No Abstract]   [Full Text] [Related]  

  • 30. [Present status of chemotherapy in human neoplastic diseases].
    PIRWITZ J
    Klin Wochenschr; 1957 May; 35(9):440-8. PubMed ID: 13450239
    [No Abstract]   [Full Text] [Related]  

  • 31. Some data in anti-cancer experiments.
    OKAMOTO H; KOSHIMURA S; HIRATA R; MURASAWA K; BANDO Y; SHIMIZU R
    Z Krebsforsch; 1958; 62(4):408-18. PubMed ID: 13604612
    [No Abstract]   [Full Text] [Related]  

  • 32. Some problems of anti-neoplastic chemotherapy.
    BIERMAN HR
    Proc West Pharmacol Soc; 1961; 4():1-3. PubMed ID: 13869073
    [No Abstract]   [Full Text] [Related]  

  • 33. New anti-neoplastic drug test using in vitro model: what to be concern?
    Wiwanitkit V
    Daru; 2012 Oct; 20(1):65. PubMed ID: 23351339
    [No Abstract]   [Full Text] [Related]  

  • 34. In Silico Investigation on the Molecular Behavior and Structural Stability of the Rosette Nanotubes as the Drug Vehicles for Paclitaxel, an Anti-Cancer Drug.
    Ali HNM; Gonzales AA
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 4-Nerolidylcatechol: apoptosis by mitochondrial mechanisms with reduction in cyclin D1 at G0/G1 stage of the chronic myelogenous K562 cell line.
    Benfica PL; Ávila RI; Rodrigues BDS; Cortez AP; Batista AC; Gaeti MPN; Lima EM; Rezende KR; Valadares MC
    Pharm Biol; 2017 Dec; 55(1):1899-1908. PubMed ID: 28644062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Base-modified thymidines capable of terminating DNA synthesis are novel bioactive compounds with activity in cancer cells.
    Borland KM; AbdulSalam SF; Solivio MJ; Burke MP; Wolfkiel PR; Lawson SM; Stockman CA; Andersen JM; Smith S; Tolstolutskaya JN; Gurjar PN; Bercz AP; Merino EJ; Litosh VA
    Bioorg Med Chem; 2015 Apr; 23(8):1869-81. PubMed ID: 25778768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Degradation of NF-κB, p53 and other regulatory redox-sensitive proteins by thiol-conjugating and -nitrosylating drugs in human tumor cells.
    Paranjpe A; Srivenugopal KS
    Carcinogenesis; 2013 May; 34(5):990-1000. PubMed ID: 23354308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concomitant combination of active immunotherapy and carboplatin- or paclitaxel-based chemotherapy improves anti-tumor response.
    Diaz Y; Tundidor Y; Lopez A; Leon K
    Cancer Immunol Immunother; 2013 Mar; 62(3):455-69. PubMed ID: 22941039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic studies of anti-neoplastic drugs on human lymphocytes--in vitro studies.
    Krishna IV; Vanaja GR; Kumar NS; Suman G
    Cancer Biomark; 2009; 5(6):261-72. PubMed ID: 20037202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the effectiveness of selected non-steroidal anti-inflammatory drugs and their derivatives against cancer cells in vitro.
    Andrews P; Zhao X; Allen J; Li F; Chang M
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):203-14. PubMed ID: 17447067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.